Literature DB >> 23166285

The road to competitive generic drug prices in Canada.

Michael R Law, Jillian Kratzer.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23166285      PMCID： PMC3778465          DOI： 10.1503/cmaj.121367

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  Lowering generic drug prices: less regulation equals more competition.

Authors:  Aslam H Anis; Daphne P Guh; John Woolcott
Journal:  Med Care       Date:  2003-01       Impact factor: 2.983

2.  Geographic accessibility of community pharmacies in ontario.

Authors:  Michael R Law; Anna Dijkstra; Jay A Douillard; Steven G Morgan
Journal:  Healthc Policy       Date:  2011-02

3.  Purchasing prescription drugs in Canada: hang together or hang separately.

Authors:  Michael R Law; Steven G Morgan
Journal:  Healthc Policy       Date:  2011-05

4.  Provincial experiments aim to lower public drug plan costs.

Authors:  Ann Silversides
Journal:  CMAJ       Date:  2009-09-01       Impact factor: 8.262

5.  Drug shortages: searching for a cure.

Authors:  Marc-André Gagnon
Journal:  Healthc Policy       Date:  2012-05

6.  The effect of cost on adherence to prescription medications in Canada.

Authors:  Michael R Law; Lucy Cheng; Irfan A Dhalla; Deborah Heard; Steven G Morgan
Journal:  CMAJ       Date:  2012-01-16       Impact factor: 8.262

7.  Pharmaceuticals, patents, and politics: Canada and Bill C-22.

Authors:  J Lexchin
Journal:  Int J Health Serv       Date:  1993       Impact factor: 1.663

8.  Effect of generic drug competition on the price of prescription drugs in Ontario.

Authors:  J Lexchin
Journal:  CMAJ       Date:  1993-01-01       Impact factor: 8.262

9.  Influencing Drug Prices through Formulary-Based Policies: Lessons from New Zealand.

Authors:  Steve Morgan; Gillian Hanley; Meghan McMahon; Morris Barer
Journal:  Healthc Policy       Date:  2007-08
  9 in total
  9 in total

1.  Money left on the table: generic drug prices in Canada.

Authors:  Michael R Law
Journal:  Healthc Policy       Date:  2013-02

2.  The consequences of patient charges for prescription drugs in Canada: a cross-sectional survey.

Authors:  Michael R Law; Lucy Cheng; Ashra Kolhatkar; Laurie J Goldsmith; Steven G Morgan; Anne M Holbrook; Irfan A Dhalla
Journal:  CMAJ Open       Date:  2018-02-05

3.  Comparison of United States and canadian glaucoma medication costs and price change from 2006 to 2013.

Authors:  Matthew B Schlenker; Graham E Trope; Yvonne M Buys
Journal:  J Ophthalmol       Date:  2015-04-01       Impact factor: 1.909

4.  Pan-Canadian overpricing of medicines: a 6-country study of cost control for generic medicines.

Authors:  Reed F Beall; Jason W Nickerson; Amir Attaran
Journal:  Open Med       Date:  2014-10-14

5.  A Better Prescription: Advice for a National Strategy on Pharmaceutical Policy in Canada.

Authors:  Steven G Morgan; Marc-André Gagnon; Barbara Mintzes; Joel Lexchin
Journal:  Healthc Policy       Date:  2016-08

6.  Merger mania: mergers and acquisitions in the generic drug sector from 1995 to 2016.

Authors:  Marc-André Gagnon; Karena D Volesky
Journal:  Global Health       Date:  2017-08-22       Impact factor: 4.185

7.  Health Services Research Spending and Healthcare System Impact Comment on "Public Spending on Health Service and Policy Research in Canada, the United Kingdom, and the United States: A Modest Proposal".

Authors:  Morris L Barer; Stirling Bryan
Journal:  Int J Health Policy Manag       Date:  2018-03-01

8.  Ontario and New Zealand Pharmaceuticals: Cost and Coverage.

Authors:  Leah T Kelley; Tim Tenbensel; Ana Johnson
Journal:  Healthc Policy       Date:  2018-05

9.  The Impact of Tiered-Pricing Framework on Generic Entry in Canada.

Authors:  Wei Zhang; Huiying Sun; Daphne P Guh; Larry D Lynd; Aidan Hollis; Paul Grootendorst; Aslam H Anis
Journal:  Int J Health Policy Manag       Date:  2022-06-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.